4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001209191-22-053456
EVP, Global Sales & Marketing sold 29,133 shares at an average $6.46 ($188,165)
- EVP, Global Sales & Marketing acquired 29,133 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ross Thomas M. · EVP, Global Sales & Marketing
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-10-10 | Exercise or conversion : show line 1 in the form | +24,851 | $0.84 | $20,875 | 24,851 | D |
| 2022-10-10 | Sale : show line 2 in the form | −24,851 | $6.45 | $160,289 | 0 | D |
| 2022-10-11 | Exercise or conversion : show line 3 in the form | +4,282 | $0.84 | $3,597 | 4,282 | D |
| 2022-10-11 | Sale : show line 4 in the form | −4,282 | $6.51 | $27,876 | 0 | D |
| Open-market sales · 29,133 sh · avg $6.46 · $188,165 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-10-10 | Exercise or conversion : show line 5 in the form Employee Stock Option (right to buy) | −24,851 | 32,149 | D |
| 2022-10-11 | Exercise or conversion : show line 6 in the form Employee Stock Option (right to buy) | −4,282 | 27,867 | D |
Loading xslF345X03/doc4.xml…